Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report. (30th June 2011)

• Record Type: Journal Article
• Authors: Colaci, Michele; Sebastiani, Marco; Sandri, Gilda; Meacci, Marisa; Ferri, Clodoveo
• Other Names: Chierakul W. Academic Editor.; Mansour-Ghanaei F. Academic Editor.; Meyer C. G. Academic Editor.
• Is Part Of: Case reports in infectious diseases. Volume 2011(2011)
• Publication Date: 2011-06-30
• Subjects: Communicable diseases -- Periodicals; Communicable diseases -- Case studies -- Periodicals; Communicable Diseases; Infectious Disease Medicine; Communicable diseases; Electronic journals; Periodicals; Case studies; Periodicals; 616.9
• DOI: 10.1155/2011/530568
• Languages: English
• ISSNs: 2090-6625

Abstract

Abstract : TNF-alpha blockers represent one of the most important therapeutic strategies for rheumatoid arthritis, but their use has raised the question about their safety profile, particularly in respect to viral infections/reactivations. We describe the case of a patient who developed a symptomatic EBV reactivation 11 days after the first infusion of infliximab.